Chapter/Section Purchase

1 Study Coverage
1.1 Amyloidosis Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Amyloidosis Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AG-10
1.2.3 ALN-ANG
1.2.4 ALN-TTRsc02
1.2.5 CAEL-101
1.2.6 Canakinumab
1.2.7 Others
1.3 Market by Application
1.3.1 Global Amyloidosis Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 AL Amyloidosis
1.3.3 AA Amyloidoses
1.3.4 ATTR Amyloidoses
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Amyloidosis Therapeutics Sales Estimates and Forecasts 2017-2028
2.2 Global Amyloidosis Therapeutics Revenue Estimates and Forecasts 2017-2028
2.3 Global Amyloidosis Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Amyloidosis Therapeutics Sales by Region
2.4.1 Global Amyloidosis Therapeutics Sales by Region (2017-2022)
2.4.2 Global Sales Amyloidosis Therapeutics by Region (2023-2028)
2.5 Global Amyloidosis Therapeutics Revenue by Region
2.5.1 Global Amyloidosis Therapeutics Revenue by Region (2017-2022)
2.5.2 Global Amyloidosis Therapeutics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Amyloidosis Therapeutics Sales by Manufacturers
3.1.1 Global Top Amyloidosis Therapeutics Manufacturers by Sales (2017-2022)
3.1.2 Global Amyloidosis Therapeutics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Amyloidosis Therapeutics in 2021
3.2 Global Amyloidosis Therapeutics Revenue by Manufacturers
3.2.1 Global Amyloidosis Therapeutics Revenue by Manufacturers (2017-2022)
3.2.2 Global Amyloidosis Therapeutics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Amyloidosis Therapeutics Revenue in 2021
3.3 Global Amyloidosis Therapeutics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Amyloidosis Therapeutics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Amyloidosis Therapeutics Sales by Type
4.1.1 Global Amyloidosis Therapeutics Historical Sales by Type (2017-2022)
4.1.2 Global Amyloidosis Therapeutics Forecasted Sales by Type (2023-2028)
4.1.3 Global Amyloidosis Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global Amyloidosis Therapeutics Revenue by Type
4.2.1 Global Amyloidosis Therapeutics Historical Revenue by Type (2017-2022)
4.2.2 Global Amyloidosis Therapeutics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Amyloidosis Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global Amyloidosis Therapeutics Price by Type
4.3.1 Global Amyloidosis Therapeutics Price by Type (2017-2022)
4.3.2 Global Amyloidosis Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Amyloidosis Therapeutics Sales by Application
5.1.1 Global Amyloidosis Therapeutics Historical Sales by Application (2017-2022)
5.1.2 Global Amyloidosis Therapeutics Forecasted Sales by Application (2023-2028)
5.1.3 Global Amyloidosis Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global Amyloidosis Therapeutics Revenue by Application
5.2.1 Global Amyloidosis Therapeutics Historical Revenue by Application (2017-2022)
5.2.2 Global Amyloidosis Therapeutics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Amyloidosis Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global Amyloidosis Therapeutics Price by Application
5.3.1 Global Amyloidosis Therapeutics Price by Application (2017-2022)
5.3.2 Global Amyloidosis Therapeutics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Amyloidosis Therapeutics Market Size by Type
6.1.1 North America Amyloidosis Therapeutics Sales by Type (2017-2028)
6.1.2 North America Amyloidosis Therapeutics Revenue by Type (2017-2028)
6.2 North America Amyloidosis Therapeutics Market Size by Application
6.2.1 North America Amyloidosis Therapeutics Sales by Application (2017-2028)
6.2.2 North America Amyloidosis Therapeutics Revenue by Application (2017-2028)
6.3 North America Amyloidosis Therapeutics Market Size by Country
6.3.1 North America Amyloidosis Therapeutics Sales by Country (2017-2028)
6.3.2 North America Amyloidosis Therapeutics Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Amyloidosis Therapeutics Market Size by Type
7.1.1 Europe Amyloidosis Therapeutics Sales by Type (2017-2028)
7.1.2 Europe Amyloidosis Therapeutics Revenue by Type (2017-2028)
7.2 Europe Amyloidosis Therapeutics Market Size by Application
7.2.1 Europe Amyloidosis Therapeutics Sales by Application (2017-2028)
7.2.2 Europe Amyloidosis Therapeutics Revenue by Application (2017-2028)
7.3 Europe Amyloidosis Therapeutics Market Size by Country
7.3.1 Europe Amyloidosis Therapeutics Sales by Country (2017-2028)
7.3.2 Europe Amyloidosis Therapeutics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Amyloidosis Therapeutics Market Size by Type
8.1.1 Asia Pacific Amyloidosis Therapeutics Sales by Type (2017-2028)
8.1.2 Asia Pacific Amyloidosis Therapeutics Revenue by Type (2017-2028)
8.2 Asia Pacific Amyloidosis Therapeutics Market Size by Application
8.2.1 Asia Pacific Amyloidosis Therapeutics Sales by Application (2017-2028)
8.2.2 Asia Pacific Amyloidosis Therapeutics Revenue by Application (2017-2028)
8.3 Asia Pacific Amyloidosis Therapeutics Market Size by Region
8.3.1 Asia Pacific Amyloidosis Therapeutics Sales by Region (2017-2028)
8.3.2 Asia Pacific Amyloidosis Therapeutics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Amyloidosis Therapeutics Market Size by Type
9.1.1 Latin America Amyloidosis Therapeutics Sales by Type (2017-2028)
9.1.2 Latin America Amyloidosis Therapeutics Revenue by Type (2017-2028)
9.2 Latin America Amyloidosis Therapeutics Market Size by Application
9.2.1 Latin America Amyloidosis Therapeutics Sales by Application (2017-2028)
9.2.2 Latin America Amyloidosis Therapeutics Revenue by Application (2017-2028)
9.3 Latin America Amyloidosis Therapeutics Market Size by Country
9.3.1 Latin America Amyloidosis Therapeutics Sales by Country (2017-2028)
9.3.2 Latin America Amyloidosis Therapeutics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Amyloidosis Therapeutics Market Size by Type
10.1.1 Middle East and Africa Amyloidosis Therapeutics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Amyloidosis Therapeutics Revenue by Type (2017-2028)
10.2 Middle East and Africa Amyloidosis Therapeutics Market Size by Application
10.2.1 Middle East and Africa Amyloidosis Therapeutics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Amyloidosis Therapeutics Revenue by Application (2017-2028)
10.3 Middle East and Africa Amyloidosis Therapeutics Market Size by Country
10.3.1 Middle East and Africa Amyloidosis Therapeutics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Amyloidosis Therapeutics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Overview
11.1.3 Pfizer Inc. Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Inc. Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Inc. Recent Developments
11.2 ProteoTech, Inc.
11.2.1 ProteoTech, Inc. Corporation Information
11.2.2 ProteoTech, Inc. Overview
11.2.3 ProteoTech, Inc. Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 ProteoTech, Inc. Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ProteoTech, Inc. Recent Developments
11.3 Alnylam Pharmaceuticals, Inc.
11.3.1 Alnylam Pharmaceuticals, Inc. Corporation Information
11.3.2 Alnylam Pharmaceuticals, Inc. Overview
11.3.3 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Alnylam Pharmaceuticals, Inc. Recent Developments
11.4 Arcturus Therapeutics, Inc
11.4.1 Arcturus Therapeutics, Inc Corporation Information
11.4.2 Arcturus Therapeutics, Inc Overview
11.4.3 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Arcturus Therapeutics, Inc Recent Developments
11.5 Bellus Health Inc.
11.5.1 Bellus Health Inc. Corporation Information
11.5.2 Bellus Health Inc. Overview
11.5.3 Bellus Health Inc. Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bellus Health Inc. Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bellus Health Inc. Recent Developments
11.6 Bsim2
11.6.1 Bsim2 Corporation Information
11.6.2 Bsim2 Overview
11.6.3 Bsim2 Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bsim2 Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bsim2 Recent Developments
11.7 Celgene Corporation
11.7.1 Celgene Corporation Corporation Information
11.7.2 Celgene Corporation Overview
11.7.3 Celgene Corporation Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Celgene Corporation Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Celgene Corporation Recent Developments
11.8 Millennium Pharmaceuticals, Inc.
11.8.1 Millennium Pharmaceuticals, Inc. Corporation Information
11.8.2 Millennium Pharmaceuticals, Inc. Overview
11.8.3 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Millennium Pharmaceuticals, Inc. Recent Developments
11.9 Onyx Pharmaceuticals, Inc.
11.9.1 Onyx Pharmaceuticals, Inc. Corporation Information
11.9.2 Onyx Pharmaceuticals, Inc. Overview
11.9.3 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Onyx Pharmaceuticals, Inc. Recent Developments
11.10 GlaxoSmithKline Plc
11.10.1 GlaxoSmithKline Plc Corporation Information
11.10.2 GlaxoSmithKline Plc Overview
11.10.3 GlaxoSmithKline Plc Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 GlaxoSmithKline Plc Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GlaxoSmithKline Plc Recent Developments
11.11 Isis Pharmaceuticals, Inc.
11.11.1 Isis Pharmaceuticals, Inc. Corporation Information
11.11.2 Isis Pharmaceuticals, Inc. Overview
11.11.3 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Isis Pharmaceuticals, Inc. Recent Developments
11.12 Prothena Corporation Plc
11.12.1 Prothena Corporation Plc Corporation Information
11.12.2 Prothena Corporation Plc Overview
11.12.3 Prothena Corporation Plc Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Prothena Corporation Plc Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Prothena Corporation Plc Recent Developments
11.13 SOM Innovation Biotech SL
11.13.1 SOM Innovation Biotech SL Corporation Information
11.13.2 SOM Innovation Biotech SL Overview
11.13.3 SOM Innovation Biotech SL Amyloidosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 SOM Innovation Biotech SL Amyloidosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 SOM Innovation Biotech SL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Amyloidosis Therapeutics Industry Chain Analysis
12.2 Amyloidosis Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Amyloidosis Therapeutics Production Mode & Process
12.4 Amyloidosis Therapeutics Sales and Marketing
12.4.1 Amyloidosis Therapeutics Sales Channels
12.4.2 Amyloidosis Therapeutics Distributors
12.5 Amyloidosis Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Amyloidosis Therapeutics Industry Trends
13.2 Amyloidosis Therapeutics Market Drivers
13.3 Amyloidosis Therapeutics Market Challenges
13.4 Amyloidosis Therapeutics Market Restraints
14 Key Findings in The Global Amyloidosis Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer